Through the standards DIN EN ISO 9001 and 13485, validation is present
also in the field of medical devices. 21 CFR 820 requires validation for
medical devices distributed in the US. However, all these regulations
include few concrete statements.
On some specific topics, like e.g. sterilisation processes, there are a
number of standards going deeper into technical matters. One current
example is a final draft by ISO titled "Packaging for terminally sterilized medical
devices -- Part 2: Validation requirements for forming, sealing and
assembly processes (ISO 11607-2)".
This draft for a standard comprises 12 pages - with an informative
annex on process development and a reference list. The draft also contains
a matrix - also as an annex - showing the relationship between the EC
Guideline 93/42/EEC and this standard.
The definitions listed in the draft reference ISO/TS 11139/2001. It is
conspicuous that IQ OQ and PQ are defined in a similar way as in the
pharmaceutical regulations. The same goes for the definition of process
validation. The focus of this standard is on chapter 5 "Validation of
Packaging Processes". Apart from a general introduction, it contains
the subchapters IQ, OQ and PQ as well as information on the release of
process validation, process control, monitoring, on change control and on
revalidation. As a minimum requirement for process validation, IQ-PQ has
to be conducted. After that, "old products" can be validated on
the basis of data gained in earlier IQs and OQs. At least the critical
parameters can be deduced from these data. In case of similar processes, a
"worst-case" validation is allowed if based on a
rationale. The chapter IQ provides examples of the contents, reaching
from specifications on design features to operating instructions that have
to be observed within the framework of IQ. Safety aspects are also
mentioned in the IQ chapter, as is software validation. An additional
subtopic defines data concerning functional tests. What is especially
mentioned with regard to IQ is the call for a definition of the critical
process parameters as well as for their control and monitoring. The
chapter also includes the requirement to have a maintenance programme and
cleaning schedules. In OQ, the upper and lower parameter limits are meant to
be found. Quality aspects that have to be observed are mentioned with
regard to forming/assembly, sealing and other container closure systems. It
is the aim of PQ to demonstrate that the process constantly generates a
closure system within the limits tested during OQ. The requirements on the
contents of the PQ again point out the importance of repeatability and
processability. Challenge tests are set out in detail (e.g. power failure,
shift change, upgrading the facility). As a minimum, 3 production
runs of sufficient length are required. In addition, the text points to
the predefined requirements that have to be fulfilled. Process validation
is then to be revised and formally released. Afterwards, a summarizing
documentation describes the validation status - taking into account
monitoring of controls and the process and its documentation. Besides, the standard
requires a regulated process for change control and a revalidation -
in case major changes have been made. It also includes a list of changes
that could be relevant to revalidation. The necessity of a revalidation
should be assessed. It is expressly mentioned that the scope of a
revalidation does not have to be identical with that of a first
validation. Periodic revalidations or reviews should be conducted, since
minor changes could have a cumulative effect on the validation status. Final
analysis: The numerous parallels to qualification activities in the
pharmaceutical industry are striking. However, Design Qualification is
left out completely as there are differences in the terminology between
the medical device area and the pharmaceutical sphere. A slight difference
to the pharmaceutical environment is the global summary of IQ, OQ and PQ
as process validation. It is surprising that 3 batches of product are
still to be manufactured within the framework of PQ - a number from which
the pharmaceutical industry is starting to depart.
Author:
Sven Pommeranz
On behalf of ECA
Source:
Packaging
for terminally sterilized medical devices -- Part 2: Validation
requirements for forming, sealing and assembly processes (ISO
11607-2:2006)
|